Stamford, CT -- (SBWIRE) -- 12/11/2013 -- OTC Stock Picks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Titan Pharmaceuticals, Inc.(OTCBB:TTNP), GeoVax Labs, Inc (OTCMKTS:GOVX), Tesco PLC (ADR)(OTCMKTS:TSCDY), Exide Technologies(OTCMKTS:XIDEQ)
Titan Pharmaceuticals, Inc.(OTCBB:TTNP) increased 2.44% at the price of $0.840 recently on a traded volume of 496,383.00 shares, in comparison to 271,504.00 shares of average trading volume. So far this year, the stock is down over -24.36%.
The company has a total market capitalization of $68.68 million and its total outstanding shares are 10.87 million. Titan Pharmaceuticals, Inc. is a biopharmaceutical company developing proprietary therapeutics primarily for the treatment of central nervous system (CNS) disorders. The Company is focused primarily on clinical development of the following products: Probuphine for the treatment of opioid addiction; Iloperidone: for the treatment of schizophrenia and related psychotic disorders; and Spheramine for the treatment of advanced Parkinson’s disease.
For How Long TTNP will Fight for Profitability? Read This Trend Analysis report
GeoVax Labs, Inc (OTCMKTS:GOVX) soared 41.94% at the trading price of $0.880 on a traded volume of 353,796.00 shares till now, whereas its average trading volume is 69,647.00 shares. In the last three months, the stock is up 86.96%. The Intra-day range for the stock is $0.62 and $0.90. GeoVax Labs, Inc. (GeoVax) is a biotechnology company that prevent and fight human immunodeficiency virus (HIV). The Company’s vaccines prevent HIV infection and to serve as a treatment for individuals who are already infected with HIV. These vaccines are being evaluated in humans both in those infected with HIV and those who are not.
For How Long GOVX Gloss will Attract Investors? Find out via this report
Tesco PLC (ADR)(OTCMKTS:TSCDY) dropped down -0.92% at the $16.18 recently. So far in three months, the stock is down -1.58%. The 52-week range for the stock is $15.10 and $18.51. Its introductory price for the day was $16.27, with the overall traded volume of 303,846.00 shares. Tesco PLC is an international retailer. The activity of the Company is retailing and associated activities in the United Kingdom, the People’s Republic of China, the Czech Republic, Hungary, the Republic of Ireland, India, Malaysia, Poland, Slovakia, South Korea, Thailand, Turkey and the United States.
Why Should Investors Buy TSCDY After the Recent Fall? Just Go Here and Find Out
Exide Technologies(OTCMKTS:XIDEQ), after opening its shares at the price of $0.22, dropped -6.43% , its recent trading price was $0.215 for the day. The stock moved on a traded volume of 147,985.0 shares, in comparison to 839,122.00 shares of average trading volume.
The 52-week range for the stock is $0.01 and $3.90. Its introductory price for the day was $0.22. Exide Technologies is engaged in stored electrical energy solutions, and is a manufacturer and supplier of lead-acid batteries for transportation and industrial applications in the worldwide. Exide operates in four business segments: Transportation Americas, Transportation Europe and ROW,
Will XIDEQ Get Buyers Even After The Recent Rally? Find Out Here
About OTC Stock Picks
The team is among the US market leaders in connecting stocks to investors. With over two decades of market experience, the team prides itself on having the ‘pulse’ of the stock market. The company tracks over 100 different stocks with the goal of bringing investor attention to stock trading opportunities. The team is exceptional at predicting momentum-changes in stocks via technical analysis and fundamentals, and quickly relaying this information through its penny stock newsletter. The company offers investors Free Level II service and Free Real Time Stock Charts on its company website.
OTC Stock Picks is not a registered securities adviser. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and company website, but this should not be construed as a recommendation to buy or sell.
Read full disclaimer at: http://otcstockpicks.net/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)